Biomarkers From Discovery to Clinical Application: In Silico Pre-Clinical Validation Approach in the Face of Lung Cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKori, Medi
dc.contributor.authorGov, Esra
dc.contributor.authorArga, Kazim Yalcin
dc.contributor.authorSinha, Raghu
dc.date.accessioned2025-10-16T15:13:54Z
dc.date.issued2024
dc.identifier.doi10.1177/11772719241287400
dc.identifier.otherWOS:001326130000001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5988
dc.publisherSAGE PUBLICATIONS LTD
dc.sourceBIOMARKER INSIGHTS
dc.subjectProtein biomarkers
dc.subjectin silico pre\\-clinical validation step
dc.subjectlung cancer
dc.subjectoncoprotein
dc.subjecttumor suppressor
dc.subjectcancer hallmark
dc.subjectbody fluids
dc.subjectapproved drugs
dc.titleBiomarkers From Discovery to Clinical Application: In Silico Pre-Clinical Validation Approach in the Face of Lung Cancer
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS